Research Calls
- Upgrades:
- BioMarin Pharmaceutical (BMRN) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $110
- Ceridian HCM (CDAY) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $64
- Cullen/Frost (CFR) upgraded to In-line from Underperform at Evercore ISI; tgt raised to $160
- First Bancshares (FBMS) upgraded to Outperform from Market Perform at Hovde Group; tgt $38
- Gilead Sciences (GILD) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $76
- Imperial Oil (IMO) upgraded to Outperform from Market Perform at BMO Capital Markets
- TAL Education (TAL) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $4.70
- TrueCar (TRUE) upgraded to Overweight from Underweight at JP Morgan
- Downgrades:
- ABB Ltd (ABB) downgraded to Buy from Conviction Buy at Goldman
- Advanced Micro (AMD) downgraded to Market Perform from Outperform at Northland Capital; tgt lowered to $60
- Ameris Bancorp (ABCB) downgraded to Mkt Perform from Outperform at Raymond James
- Amgen (AMGN) downgraded to Underweight from Equal Weight at Barclays; tgt $234
- Aon (AON) downgraded to Underperform from Mkt Perform at Raymond James
- Caterpillar (CAT) downgraded to Neutral from Buy at UBS; tgt raised to $230
- Cedar Fair (FUN) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $42
- DaVita(DVA) downgraded to Neutral from Buy at UBS; tgt lowered to $74
- DT Midstream (DTM) downgraded to Neutral from Buy at Mizuho; tgt lowered to $62
- Greif (GEF) downgraded to Underperform from Market Perform at BMO Capital Markets; tgt lowered to $62
- Hanesbrands (HBI) downgraded to Underweight from Overweight at Wells Fargo; tgt lowered to $5
- Heritage Commerce Corp. (HTBK) downgraded to Outperform from Strong Buy at Raymond James; tgt raised to $15
- Honeywell (HON) downgraded to Neutral from Outperform at Daiwa Securities; tgt lowered to $194
- Keurig Dr Pepper (KDP) downgraded to Sell from Hold at Truist; tgt lowered to $30
- LyondellBasell (LYB) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $82
- Paramount Global (PARA) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $13
- Petrobras (PBR) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $14
- Principal Fincl (PFG) downgraded to Underperform from Mkt Perform at Keefe Bruyette; tgt raised to $77
- Reinsurance Group of America (RGA) downgraded to Neutral from Overweight at JP Morgan; tgt $136
- Sonoco Products (SON) downgraded to Underperform from Market Perform at BMO Capital Markets; tgt lowered to $58
- Texas Roadhouse (TXRH) downgraded to Hold from Buy at Deutsche Bank; tgt raised to $101
- Vitru (VTRU) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt $23.50
- Y-mAbs Therapeutics (YMAB) downgraded to Neutral from Outperform at Wedbush; tgt $6
- Y-mAbs Therapeutics (YMAB) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $7
- Others:
- 2seventy bio (TSVT) initiated with a Buy at Guggenheim; tgt $30
- Arcellx (ACLX) initiated with a Buy at Guggenheim; tgt $36
- Ares Commercial Real Estate (ACRE) resumed with a Buy at BofA Securities; tgt $13
- Business First Bancshares (BFST) initiated with an Outperform at Raymond James; tgt $28
- Bumble Inc. (BMBL) initiated with a Sector Weight at KeyBanc Capital Markets
- Century Therapeutics (IPSC) initiated with a Buy at Guggenheim; tgt $15
- Doximity (DOCS) initiated with an Overweight at Wells Fargo; tgt $38
- FREYR Battery (FREY) initiated with an Outperform at Cowen
- Gritstone bio (GRTS) initiated with an Overweight at Piper Sandler; tgt $6
- Health Catalyst (HCAT) initiated with an Equal Weight at Wells Fargo; tgt $10
- Iovance Biotherapeutics (IOVA) initiated with a Neutral at Guggenheim
- Kaman (KAMN) resumed with an Underweight at JP Morgan; tgt lowered to $37
- Ladder Capital (LADR) resumed with a Neutral at BofA Securities; tgt $11
- Legend Biotech (LEGN) initiated with a Neutral at Guggenheim
- Outlook Therapeutics (OTLK) initiated with a Buy at BTIG Research; tgt $7
- PROCEPT BioRobotics (PRCT) initiated with a Neutral at BTIG Research
- Veeva Systems (VEEV) initiated with an Equal Weight at Wells Fargo; tgt $180